Found: 4
Select item for more details and to access through your institution.
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
- Published in:
- Medical Science Monitor, 2020, v. 26, p. 1, doi. 10.12659/MSM.924497
- By:
- Publication type:
- Article
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 5225, doi. 10.2147/DDDT.S87526
- By:
- Publication type:
- Article
MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 329, doi. 10.2147/CMAR.S284220
- By:
- Publication type:
- Article
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
- Published in:
- Journal of Ovarian Research, 2015, v. 8, p. 1, doi. 10.1186/s13048-015-0207-6
- By:
- Publication type:
- Article